NOTICE OF GOOD FAITH ESTIMATE OF NON-DEDUCTIBILITY OF NYSPA 2016 DUES
The Omnibus Budget Reconciliation Act of 1993 included certain provisions denying tax deductibility for the portion of dues paid to 501(c)(6) professional organizations that is spent on influencing state or federal legislation. The law requires NYSPA to provide its members with a good-faith estimate of the portion of their dues which is attributable to lobbying and therefore, is non-deductible for federal income tax purposes.
For 2016 dues, NYSPA has estimated that 40% of NYSPA/Area II dues are attributable to lobbying and cannot be deducted. The schedule below sets forth the calculation of the deductible and non-deductible portion assuming payment in full. If only a partial payment was made, then 40% of the amount paid is non-deductible.
Membership Category 2016 Dues Deductible Non-deductible
General Member/Fellow 195.00 117.00 78.00
Member in Training 15.00 9.00 6.00
Life Member/Life Fellow (1-5) 130.00 78.00 52.00
Life Member/Life Fellow (6-10) 65.00 39.00 26.00
Please note that this notification only applies to NYSPA/Area II dues. It does not apply to APA dues or to district branch dues. If you have any questions, please do not hesitate to contact the NYSPA Central Office.
NYSPA Honors C. Deborah Cross, M.D. with Distinguished Service Award
At its Spring meeting on March 22, 2014, the NYSPA Council awarded the NYSPA Distinguished Service Award to C. Deborah Cross, M.D. in recognition of her dedication, prodigious effort, intelligence and leadership in the profession of Psychiatric Medicine nationally and in the State of New York.
NYSPA congratulates Lois Kroplick, D.O. on being named 2014 Physician of the Year Award by the New York State Osteopathic Medical Society. The award was presented on February 21st at the President’s Reception during the 2014 Regional Osteopathic Convention.
Dr. Kroplick is the first psychiatrist to have received this honor. Click here to view a copy of Dr. Kroplick's acceptance speech.
Andrew Kolodny, MD appointed Chief Medical Office, Phoenix House
NEW YORK--(BUSINESS WIRE)--Phoenix House, the nation’s leading nonprofit provider of substance abuse and treatment and prevention services, announced today its appointment of Andrew Kolodny, M.D., a nationally recognized psychiatrist and public health advocate, as Chief Medical Officer, effective September 9, 2013.